Treatment of Dizziness using virtual reality
- Conditions
- Symptoms, signs and abnormal clinical and laboratory findings, NEC
- Registration Number
- KCT0003864
- Lead Sponsor
- Pusan National University Hospital
- Brief Summary
To determine the effect of customized vestibular exercise (VE) and optokinetic stimulation (OS) using a virtual reality system in patients with persistent postural-perceptual dizziness (PPPD). Patients diagnosed with PPPD were randomly assigned to the VE group or VE with OS group. All participants received VE for 20 min using a virtual reality system with a head mount display once a week for 4 weeks. The patients in the VE with OS group additionally received OS for 9 min. We analysed the questionnaires, timed up-to-go (TUG) test, and posturography scores at baseline and after 4 weeks. A total of 28 patients (median age = 74.5, IQR 66–78, men = 12) completed the intervention. From baseline to 4 weeks, the dizziness handicap inventory, activities of daily living (ADL), visual vertigo analogue scale, and TUG improved in the VE group, but only ADL and TUG improved in the VE with OS group. Patients with severe visual vertigo improved more on their symptoms than patients with lesser visual vertigo (Pearson’s p = 0.716, p < 0.001). Our VE program can improve dizziness, quality of life, and gait function in PPPD; however, additional optokinetic stimuli should be applied for individuals with visual vertigo symptoms.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
1. Dizziness patients with vestibular dysfunction above 18 years of age
2. Patients with vestibular dysfunction In the VOG and vHit test, or Patients with moderate to severe dizziness in DHI
3. Patients who agreed to participate in this study
1. Patients who can not sit on their own due to a disability, can not get a vestibular rehabilitation program due to high obesity, severe pain, pregnancy
2. Patients who can not accurately describe their symptoms due to cognitive impairment
3. Those who have difficulty participating in research due to clinically serious diseases (liver disease, kidney disease, malignant tumor, etc.) at the judgment of the researcher
4. Patients who are difficult to participate according to the judgment of other researchers
5. Those who did not agree to participate in the study
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dizziness Handicap Inventory
- Secondary Outcome Measures
Name Time Method Activity of Daily Living